Clinical Updates | Conference Update Resource List
Did you miss EASL or AASLD 2016? Click HERE to learn about key clinical updates in Hepatitis C presented at recent conferences.
Last Updated on May 17, 2020 by HepFree NYC
Tags: HepCX NewsRelated Articles
-
NY Governor Announces First-In-Nation Task Force To Eliminate Hepatitis C
Governor Andrew M. Cuomo today announced the nation's first strategy to eliminate hepatitis C, including the establishment of a Hepatitis C Elimination Task Force that will advise the state as it implements its plan going forward.
-
Support Funding for Viral Hepatitis–Urge Your House Representative
We have the tools to prevent the major causes of viral hepatitis and liver cancer – a hepatitis B vaccine and effective treatments that reduce disease progression, new diagnostics for HCV and treatments that increase cure rates over 90%, and even more medical advances in the re...
-
#Clinicians: Register as NYS DOH Hep C Experienced Provider
The purpose of Hep C directory is to provide the public and other providers with a listing of hepatitis C care and treatment providers within New York State.
-
Advancing HIV & Viral Hepatitis Testing with Point-Of-Care Diagnostics for People with Substance Use Disorder
SAMSHA and the CDC urges public health and substance use disorder (SUD) treatment communities to increase the number of people tested and treated for HIV and viral hepatitis.
-
Funding | Innovative Hepatitis C Care and Treatment Models for People Who Inject Drugs (NYS DOH)
This RFA will support 3 innovative HCV care and treatment models that will address the needs and the barriers PWID with HCV face when accessing HCV services in traditional health care settings.
-
Team HBV NYC
There are numerous opportunities available for students to assist NYC Hepatitis B Coalition member organizations through internships and volunteer projects.
-
Article | Evaluation of a hep C care coordination effect on treatment initiation and cure
Evaluation of whether enrollment in Project INSPIRE was associated with differences in HCV treatment and cure compared with a demographically similar group not enrolled in the programme.
-
NYS DOH Approves Viekira Pak as Preferred Drug for Hep C for FFS Medicaid Beneficiaries
YSDOH Drug Utilization Review Board meeting, the board voted to approve Viekira Pak as its preferred drug for persons chronically infected with HCV and enrolled in FFS Medicaid. Viekira Pak will be available for all chronically infected persons regardless of disease severity. Thi...
